Pharmacotherapy of Liver Fibrosis and Hepatitis: Recent Advances, 2nd Edition

Dear Colleagues,

According to the World Health Organization, of the four most prevalent infectious diseases, the incidences of tuberculosis, malaria and human immunodeficiency virus are declining (the former two since 1990, the third one since 2005), only hepatitis B and C (HBV, HCV) are continuing to increase. These two viruses can cause severe liver fibrosis as well as hepatocellular carcinoma (HCC). More recently, steatotic liver disease (SLD) has also become a major cause of HCC with and without cirrhosis. There are major developments for the treatment of these diseases.

Prof. Dr. Ching-Lung Lai
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceuticals is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.